Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst is the UK’s first open innovation bioscience campus, pioneering a unique culture to drive early stage bioscience technology and company development. It is backed by £38m of funding from GlaxoSmithKline, the Wellcome Trust and the UK Government. Consisting of an incubator, an accelerator and a hub, covering 60,000 sq ft of laboratory, office and networking space, the independent facility houses a range of companies. Located on the GlaxoSmithKline Stevenage site, Stevenage Bioscience Catalyst is in the unique position of operating in proximity to the expertise and resources of a major pharmaceutical company, close to London and Cambridge.